Ausgabe 3/2017
Inhalt (6 Artikel)
Original Paper
A Novel Strategy to Co-target Estrogen Receptor and Nuclear Factor κB Pathways with Hybrid Drugs for Breast Cancer Therapy
Irida Kastrati, Marton I. Siklos, Svitlana D. Brovkovych, Gregory R. J. Thatcher, Jonna Frasor
Original Paper
Growth Hormone Receptor Knockdown Sensitizes Human Melanoma Cells to Chemotherapy by Attenuating Expression of ABC Drug Efflux Pumps
Reetobrata Basu, Nicholas Baumgaertel, Shiyong Wu, John J. Kopchick
Open Access
Original Paper
Nanoparticulate Tetrac Inhibits Growth and Vascularity of Glioblastoma Xenografts
Thangirala Sudha, Dhruba J. Bharali, Stewart Sell, Noureldien H. E. Darwish, Paul J. Davis, Shaker A. Mousa
Original Paper
Risk of Gonadoblastoma Development in Patients with Turner Syndrome with Cryptic Y Chromosome Material
Ahreum Kwon, Sei Eun Hyun, Mo Kyung Jung, Hyun Wook Chae, Woo Jung Lee, Tae Hyuk Kim, Duk Hee Kim, Ho-Seong Kim
Original Paper
Aryl Hydrocarbon Receptor–Interacting Protein (AIP) N-Terminus Gene Mutations Identified in Pituitary Adenoma Patients Alter Protein Stability and Function
Robert Formosa, Josanne Vassallo
Original Paper
Clinical and Metabolic Response to Vitamin D Supplementation in Endometrial Hyperplasia: a Randomized, Double-Blind, Placebo-Controlled Trial
Zohreh Tabassi, Sedigheh Bagheri, Mansooreh Samimi, Hamid Reza Gilasi, Fereshteh Bahmani, Maryam Chamani, Zatollah Asemi